Header Logo

Connection

SHREYASKUMAR PATEL to Hydroxamic Acids

Back to Details
This is a "connection" page, showing publications SHREYASKUMAR PATEL has written about Hydroxamic Acids.
SHREYASKUMAR PATEL
Connection Strength
0.028
Hydroxamic Acids
  1. Phase I dose-escalation study of the mTOR inhibitor sirolimus and the HDAC inhibitor vorinostat in patients with advanced malignancy. Oncotarget. 2016 Oct 11; 7(41):67521-67531.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.